Advertisement

Brief behavioral treatment for insomnia in older adults with late-life treatment-resistant depression and insomnia: a pilot study

  • Marie Anne GebaraEmail author
  • Elizabeth A. DiNapoli
  • Lisa G. Lederer
  • Adam D. Bramoweth
  • Anne Germain
  • John W. Kasckow
  • Jordan F. Karp
Original Article

Abstract

Brief behavioral treatment for insomnia (BBTI) is an efficacious treatment of insomnia in older adults. Behavioral treatments for insomnia can also improve depression. However, it is unknown if BBTI is feasible or has an effect in patients with insomnia and late-life treatment-resistant depression (LLTRD). The aims of this study were twofold: to test (1) the feasibility (defined by acceptability and retention rates) of BBTI and (2) the therapeutic potency of BBTI on symptoms of insomnia and depression. Eleven older Veterans with LLTRD and insomnia were recruited in a randomized control trial to receive immediate (4 weeks of BBTI followed by 3 weeks of phone call check-ins and a final in-person 8-week assessment) or delayed [3 weeks of treatment as usual (wait-list control) followed by 4 weeks of BBTI and a final in-person 8-week assessment] BBTI. The primary outcome measures included the Patient Health Questionnaire (minus the sleep item) and the Insomnia Severity Index. BBTI was found to be feasible in older Veterans with insomnia and LLTRD; all participants recommended BBTI and retention rates were 90.9%. There was no difference in treatment effect between the immediate BBTI and delayed BBTI groups at week 4. After both groups (immediate and delayed) received BBTI, improvements were seen in both insomnia (d = 1.06) and depression (d = 0.54) scores. BBTI is a feasible treatment for insomnia in older adults with LLTRD. BBTI may be an effective adjunctive treatment for depression. Larger adequately powered trials are required to confirm these preliminary findings.

Keywords

Behavioral treatment Insomnia Aging Treatment-resistant depression 

Notes

Acknowledgements

The contents of this article do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.

Funding

This work was supported by the Veterns Integrated Service Network (VISN) 4 Mental Illness Research, Education, and Clinical Center Pilot Project Funds (PI: Gebara) at the Veternans Affairs Pittsburgh Healthcare System and T32 MH019986.

Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed). 2013.Google Scholar
  2. 2.
    Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111.CrossRefGoogle Scholar
  3. 3.
    Avidan AY, et al. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc. 2005;53(6):955–62.CrossRefGoogle Scholar
  4. 4.
    Spira AP, et al. Association between insomnia symptoms and functional status in U.S. older adults. J Gerontol B Psychol Sci Soc Sci. 2014;69(Suppl 1):S35–41.CrossRefGoogle Scholar
  5. 5.
    Qaseem A, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the american college of physicians. Ann Intern Med. 2016;165(2):125–33.CrossRefGoogle Scholar
  6. 6.
    Schutte-Rodin S, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.Google Scholar
  7. 7.
    National Institutes of H, National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13–15, 2005. Sleep. 2005. 28(9): p. 1049–57.Google Scholar
  8. 8.
    Harsora P, Kessmann J. Nonpharmacologic management of chronic insomnia. Am Fam Physician. 2009;79(2):125–30.Google Scholar
  9. 9.
    Buysse DJ, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med. 2011;171(10):887–95.CrossRefGoogle Scholar
  10. 10.
    Wilson SJ, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24(11):1577–601.CrossRefGoogle Scholar
  11. 11.
    Chesson AL Jr, et al. Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 1999;22(8):1128–33.CrossRefGoogle Scholar
  12. 12.
    Morgenthaler T, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep. 2006;29(11):1415–9.CrossRefGoogle Scholar
  13. 13.
    American Geriatrics Society Beers Criteria Update Expert. P., American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.CrossRefGoogle Scholar
  14. 14.
    Mulsant BH, et al. A systematic approach to pharmacotherapy for geriatric major depression. Clin Geriatr Med. 2014;30(3):517–34.CrossRefGoogle Scholar
  15. 15.
    Lenze EJ, et al. Incomplete response in late-life depression: getting to remission. Dialogues Clin Neurosci. 2008;10(4):419–30.Google Scholar
  16. 16.
    Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci. 2008;10(4):473–81.Google Scholar
  17. 17.
    Dew MA, et al. Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry. 1997;54(11):1016–24.CrossRefGoogle Scholar
  18. 18.
    Gallo JJ, et al. Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care. BMJ. 2013;346:f2570.CrossRefGoogle Scholar
  19. 19.
    Whiteford HA, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86.CrossRefGoogle Scholar
  20. 20.
    Callahan CM, et al. Treatment of depression improves physical functioning in older adults. J Am Geriatr Soc. 2005;53(3):367–73.CrossRefGoogle Scholar
  21. 21.
    Butters MA, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci. 2008;10(3):345–57.Google Scholar
  22. 22.
    Campbell DG, et al. Prevalence of depression-PTSD comorbidity: implications for clinical practice guidelines and primary care-based interventions. J Gen Intern Med. 2007;22(6):711–8.CrossRefGoogle Scholar
  23. 23.
    Fortney JC, et al. Reasons for antidepressant nonadherence among veterans treated in primary care clinics. J Clin Psychiatry. 2011;72(6):827–34.CrossRefGoogle Scholar
  24. 24.
    Matsuwaka S, Martin J, Alessi C. Insomnia in older veterans: prevalence, self-rated health, and talking to a doctor about sleep problems. Hawai’i J Med Publ Health. 2013;72(9 Suppl 4):63.Google Scholar
  25. 25.
    Manber R, et al. Efficacy of cognitive-behavioral therapy for insomnia combined with antidepressant pharmacotherapy in patients with comorbid depression and insomnia: a randomized controlled trial. J Clin Psychiatry. 2016;77(10):e1316–23.CrossRefGoogle Scholar
  26. 26.
    Carney CE, et al., Cognitive behavioral insomnia therapy for those with insomnia and depression: a randomized controlled clinical trial. Sleep, 2017. 40(4).Google Scholar
  27. 27.
    Blom K, et al. Internet treatment addressing either insomnia or depression, for patients with both diagnoses: a randomized trial. Sleep. 2015;38(2):267–77.CrossRefGoogle Scholar
  28. 28.
    Manber R, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4):489–95.CrossRefGoogle Scholar
  29. 29.
    Norell-Clarke A, et al. Group cognitive behavioural therapy for insomnia: effects on sleep and depressive symptomatology in a sample with comorbidity. Behav Res Ther. 2015;74:80–93.CrossRefGoogle Scholar
  30. 30.
    Watanabe N, et al. Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial. J Clin Psychiatry. 2011;72(12):1651–8.CrossRefGoogle Scholar
  31. 31.
    Ritterband LM, et al. Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trial. JAMA Psychiatry. 2017;74(1):68–75.CrossRefGoogle Scholar
  32. 32.
    Germain A, et al. Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med. 2006;2(4):403–6.Google Scholar
  33. 33.
    Souery D, Mendlewicz J. Compliance and therapeutic issues in resistant depression. Int Clin Psychopharmacol. 1998;13(Suppl 2):S13-8.Google Scholar
  34. 34.
    Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62(Suppl 16):10–7.Google Scholar
  35. 35.
    Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.CrossRefGoogle Scholar
  36. 36.
    Morin CM, et al. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601–8.CrossRefGoogle Scholar
  37. 37.
    Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRefGoogle Scholar
  38. 38.
    Bastien CH, Vallieres A, Morin CM. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307.CrossRefGoogle Scholar
  39. 39.
    Savard MH, et al. Empirical validation of the insomnia severity index in cancer patients. Psychooncology. 2005;14(6):429–41.CrossRefGoogle Scholar
  40. 40.
    Carney CE, et al. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep. 2012;35(2):287–302.CrossRefGoogle Scholar
  41. 41.
    Buysse DJ, et al. Recommendations for a standard research assessment of insomnia. Sleep. 2006;29(9):1155–73.CrossRefGoogle Scholar
  42. 42.
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefGoogle Scholar
  43. 43.
    Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefGoogle Scholar
  44. 44.
    Lenze EJ, et al. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386(10011):2404–12.CrossRefGoogle Scholar
  45. 45.
    Munder T, et al. Working Alliance Inventory-Short Revised (WAI-SR): psychometric properties in outpatients and inpatients. Clin Psychol Psychother. 2010;17(3):231–9.Google Scholar
  46. 46.
    Troxel WM, Germain A, Buysse DJ. Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med. 2012;10(4):266–79.CrossRefGoogle Scholar
  47. 47.
    Cohen. Statistical power analysis for the behavioral sciences. New York: Routledge Academic; 1988.Google Scholar
  48. 48.
    Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1):12–9.CrossRefGoogle Scholar
  49. 49.
    Germain A, et al. Treatment for insomnia in combat-exposed OEF/OIF/OND military veterans: preliminary randomized controlled trial. Behav Res Ther. 2014;61:78–88.CrossRefGoogle Scholar
  50. 50.
    W H, G. D, and K. P, International Population reports, U.S.C. Bereau, Editor. 2016: Washington, DC. p. 95/16-1.Google Scholar
  51. 51.
    Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci. 2003;58(3):249–65.CrossRefGoogle Scholar
  52. 52.
    Hunkeler EM, et al. Psychiatric symptoms, impaired function, and medical care costs in an HMO setting. Gen Hosp Psychiatry. 2003;25(3):178–84.CrossRefGoogle Scholar
  53. 53.
    Katon WJ, et al. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry. 2003;60(9):897–903.CrossRefGoogle Scholar
  54. 54.
    Unutzer J, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA. 1997;277(20):1618–23.CrossRefGoogle Scholar
  55. 55.
    Cuijpers P, Twisk VN, Kleiboer J, Li A, Penninx J. BW, Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014;171(4):453–62.CrossRefGoogle Scholar
  56. 56.
    Whiteford HA, Rehm DL, Baxter J, Ferrari AJ, Erskine AJ, Charlson HE, Norman FJ, Flaxman RE, Johns AD, Burstein N, Murray R, Vos CJ. T, Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86.CrossRefGoogle Scholar
  57. 57.
    Callahan CM, Counsell KK, Hendrie SR, Perkins HC, Katon AJ, Noel W, Harpole PH, Hunkeler L, Unützer EM, J and I. Investigators. Treatment of depression improves physical functioning in older adults. J Am Geriatr Soc. 2005;53(3):367–73.CrossRefGoogle Scholar
  58. 58.
    Gallo JJ, Bogner MK, Raue HR, Zee PJ, Bruce J, ML, Reynolds CF 3rd. Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care. BMJ. 2013;346:f2570.CrossRefGoogle Scholar
  59. 59.
    Bruce ML, Reynolds THT, Katz CF 3rd, Schulberg II, Mulsant HC, Brown BH, McAvay GK, Pearson GJ, Alexopoulos JL. GS., Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA. 2004;291(9):1081–91.CrossRefGoogle Scholar
  60. 60.
    Stevens J, et al. Advances and controversies in the design of obesity prevention trials. Obesity (Silver Spring). 2007;15(9):2163–70.CrossRefGoogle Scholar
  61. 61.
    Lichstein KL, et al. Telehealth cognitive behavior therapy for co-occurring insomnia and depression symptoms in older adults. J Clin Psychol. 2013;69(10):1056–65.CrossRefGoogle Scholar
  62. 62.
    Kraemer HC, et al. Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry. 2006;63(5):484–9.CrossRefGoogle Scholar
  63. 63.
    Waterman L, et al., Self-reported obstructive sleep apnea is associated with nonresponse to antidepressant pharmacotherapy in late-life depression. Depress Anxiety, 2016.Google Scholar

Copyright information

© Japanese Society of Sleep Research 2019

Authors and Affiliations

  1. 1.Department of PsychiatryUniversity of Pittsburgh School of MedicinePittsburghUSA
  2. 2.Mental Illness Research, Education and Clinical CenterVA Pittsburgh Healthcare SystemPittsburghUSA
  3. 3.Center for Health Equity Research and PromotionVA Pittsburgh Healthcare SystemPittsburghUSA
  4. 4.VA Beckley Healthcare SystemBeckleyUSA
  5. 5.Western Psychiatric Institute and ClinicPittsburghUSA

Personalised recommendations